Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation

References

• Wilhelmus KR, Liesegang TJ, Osato MS, Jones DB. Cumitech 13A, Laboratory diagnosis of ocular infections. Washington, DC: American Society for Microbiology; 1994:9–20.
   Google Scholar
• Southwick FS. Eye, ear, nose, and throat infections. In: Southwick F, ed. Infectious diseases a clinical short course. 3rd edn. New York: McGraw-Hill Education; 2014:125–32.
   Google Scholar
• Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001;85:842–7.
   PubMed Web of Science ®Google Scholar
• Cheung RPF, Dipiro JT. Vancomycin: an update. Pharmacotherapy 1986;6:153–69.
   PubMed Web of Science ®Google Scholar
• Mohammed Fayaz A, Girilal M, Mahdy SA, et al. Vancomycin bound biogenic gold nanoparticles: a different perspective for development of anti VRSA agents. Process Biochem 2011;46:636–41.
   Web of Science ®Google Scholar
• Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons. London, UK: Pharmaceutical Press; 2005.
   Google Scholar
• Vila MMDC, Oliveira RMD, Gonçalves MM, Tubino M. Analytical methods for vancomycin determination in biological fluids and in pharmaceuticals. Quim Nov 2007;30:395–9.
   Web of Science ®Google Scholar
• Gavini E, Chetoni P, Cossu M, et al. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur J Pharm Biopharm 2004;57:207–12.
   PubMed Web of Science ®Google Scholar
• Hachicha W, Kodjikian L, Fessi H. Preparation of vancomycin microparticles: importance of preparation parameters. Int J Pharm 2006;324:176–84.
   PubMed Web of Science ®Google Scholar
• Araújo J, Gonzalez E, Egea MA, et al. Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine 2009;5:394–401.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int J Pharm 2004;269:1–14.
   PubMed Web of Science ®Google Scholar
• Liu GY, Omri A, Sande L. Liposomal vancomycin for the treatment of MRSA infections; 2011. Available from: http://www.google.com/patents/WO2012149116A2?cl=en.
   Google Scholar
• Attama A, Reichl S, Müller-Goymann CC. Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm 2008;355:307–13.
   PubMed Web of Science ®Google Scholar
• Ghadiri M, Fatemi S, Vatanara A, et al. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int J Pharm 2012;424:128–37.
   PubMed Web of Science ®Google Scholar
• Hansraj GP, Singh SK, Kumar P. Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential. Int J Biol Macromol 2015;81:467–76.
   PubMed Web of Science ®Google Scholar
• Shah B, Khunt D, Bhatt H, et al. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters. Eur J Pharm Sci 2015;78:54–66.
   PubMed Web of Science ®Google Scholar
• Jeong Y-I, Na H-S, Seo D-H, et al. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int J Pharm 2008;352:317–23.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56:1257–72.
   PubMed Web of Science ®Google Scholar
• Nabi-meibodi M, Vatanara A, Rouholamini A. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method. Colloids Surf B Biointerfaces 2013;112:408–14.
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 19th Informational Suppl CLSI Doc M100-S19. Wayne, PA: CLSI; 2009.
   Google Scholar
• Ismail MM, Essam TM, Mohamed AF, Mourad FE. Screening for the antimicrobial activities of alcoholic and aqueous extracts of some common species in Egypt. Int J Microbiol Res 2012;3:200–7.
   Google Scholar
• Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 21st Informational Suppl CLSI Doc M100-S21. Wayne, PA: CLSI; 2011.
   Google Scholar
• Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003;24:1781–5.
   PubMed Web of Science ®Google Scholar
• Aksoy DY, Tanriover MD, Unal S. Antimicrobial resistance: preventable or inevitable? In: Gould IM, Meer JW van der, eds. Antibiotic policies: fighting resistance. New York: Springer Science + Business Media, LLC; 2008:113–34.
   Google Scholar
• Aksungur P, Demirbilek M, Denkbas EB, et al. Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies. J Control Release 2011;151:286–94.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–96.
   PubMed Web of Science ®Google Scholar
• Westesen K, Michel HJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 1996;129:159–73.
   Web of Science ®Google Scholar
• Abdelbary G, Fahmy RH. Diazepam-loaded solid lipid nanoparticles: design and characterization. AAPS PharmSciTech 2009;10:211–19.
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces 2003;30:129–38.
   Web of Science ®Google Scholar
• Chibowski S, Paszkiewicz M, Krupa M. Investigation of the influence of the polyvinyl alcohol adsorption on the electrical properties of Al2O3 – solution interface, thickness of the adsorption layers of PVA. Powder Technol 2000;107:251–5.
   Web of Science ®Google Scholar
• Mobarak DH, Salah S, Elkheshen SA. Formulation of ciprofloxacin hydrochloride loaded biodegradable nanoparticles: optimization of technique and process variables. Pharm Dev Technol 2013;19:891–900.
   PubMed Web of Science ®Google Scholar
• Müller RH, Vuleta GM, Kovă AB, Keck CM. Physicochemical and engineering aspects solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigation. Colloids Surf A Physicochem Eng Asp 2014;444:15–25.
   Web of Science ®Google Scholar
• Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine 2007;2:289–300.
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 2005;306:71–82.
   PubMed Web of Science ®Google Scholar
• Jenning V, Gohla S. Comparison of wax and glyceride solid lipid nanoparticles (SLN). Int J Pharm 2000;196:219–22.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–77.
   PubMed Web of Science ®Google Scholar
• Moosa RM, Choonara YE, Toit LCD, et al. In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model. Int J Pharm 2014;466:296–306.
   PubMed Web of Science ®Google Scholar
• Zakeri-milani P, Loveymi BD, Jelvehgari M, et al. The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system. Colloids Surf B Biointerfaces 2013;103:174–81.
   PubMed Web of Science ®Google Scholar
• Vitorino C, Carvalho FA, Almeida AJ, Sousa JJ, Pais AACC. The size of solid lipid nanoparticles: an interpretation from experimental design. Colloids Surf B Biointerfaces 2011;84:117–30.
   PubMed Web of Science ®Google Scholar
• Gupta H, Pharm B, Pharm M, et al. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine 2010;6:324–33.
   PubMed Web of Science ®Google Scholar